A-1 Finding the Right Time to Partner: Can You Maximize Value While Balancing Risk and Reward?
A-2 Innovative Dealmaking that Pivots on Collaboration between Competitors
A-3 Licensing Strategies in the Cloud Computing Era
A-4 Royalty Rates, Transfer Pricing, and Clean Tech
B-1 Disease Foundation-Funded Drug Development Partnerships: Structuring for Success
B-2 IP Issues in Joint Ventures
B-4 Can Rx to OTC Switch Licensing Save the Day After Patent Expiration?
B-5 Maximizing the Value of Corporate Intellectual Property Assets Following Enactment of the America Invents Act
C-1 De-risking the Target: Securing Long-Term Value across Multiple Early Stage Target Deals
C-2 Early Stage Deal Structures
C-3 Academic - Industry Licensing and Partnering: New/Emerging Models
C-4 Structuring Deals to Maximize the Ability to Enforce Your Patent Portfolio
C-5 The Now Uncertain Future of Personalized Medicine and Life Sciences Innovation
Meeting Homepage Schedule-at-a-Glance Continuing Education Plenary Sessions Workshops Speaker Bios Education Workshops LES Foundation Graduate Student Business Plan Competition Presentations Attendee List